The Austrian Pharmacological Society has awarded the renowned Heribert Konzett Prize 2018 to Andrea Hölbl-Kovacic from the Institute of Pharmacology and Toxicology (in Veronika Sexl’s group). The award recognizes outstanding achievements in experimental and clinical pharmacology. This is the first time this prize is awarded to a member of the Vetmeduni Vienna. Andrea Hölbl-Kovacic convinced the selection with her excellent publication performance on the STAT5 protein and its role in the development of acute lymphoblastic leukemia.
Named after the renowned Austrian physician, pharmacologist and pioneer in the development of asthma drugs, the Heribert Konzett Prize is a high honour from the Austrian Pharmacological Society (APHAR). It is awarded annually to young scientists under 40 from the experimental field and clinical pharmacology, who have made outstanding achievements in this research field through independent, outstanding achievements, such as multiple publications in renowned specialist journals and third-party fundraising. On September 28, 2018, APHAR officially awarded the prize at a symposium in Graz, and for the first time to an employee of Vetmeduni Vienna. For her publications about STAT5’s role in leukemia, Andrea Hölbl-Kovacic previously received the Hans Horst Meyer Award from APHAR and the Funding Award from the City of Vienna Fund.